NCT01063842View on ClinicalTrials.gov

A Study of the Tolerability of Titrated Dose Tramadol/Acetaminophen Combination Tablet in Korean Patients With Osteoarthritis

PHASE4CompletedINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

August 31, 2005

Study Completion Date

May 31, 2006

Conditions
Osteoarthritis
Interventions
DRUG

tramadol hydrochloride /acetaminophen

1 tablet of tramadol hydrochloride/acetaminophen three times daily without titration for 14 days.

DRUG

tramadol hydrochloride / acetaminophen and placebo

1 tablet of tramadol/acetaminophen in the morning, 1 tablet of placebo in the afternoon and evening for 3 days, then 1 tablet of tramadol/acetaminophen in the morning, evening and 1 tablet of placebo in the afternoon for 4 days, then 1 tablet of tramadol/acetaminophen 3 times daily for next 7 days

All Listed Sponsors
lead

Janssen Korea, Ltd., Korea

INDUSTRY

NCT01063842 - A Study of the Tolerability of Titrated Dose Tramadol/Acetaminophen Combination Tablet in Korean Patients With Osteoarthritis | Biotech Hunter | Biotech Hunter